High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Chen, Shali ^a   Mukherjee, Suranjana ^a   Chakraborty, Chandan ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Activating protein 1; Endothelial cells; Glucose; Nuclear factor B

Indexed keywords

ENDOTHELIN RECEPTOR; FIBRONECTIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; PROTEIN KINASE C; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MICROVASCULATURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VASCULAR ENDOTHELIUM;

EID: 0037302999     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00192.2002     Document Type: Article

References (40)

1. Bowie A and O'Neill LAJ. Oxidative stress and nuclear factor-κB activation. A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59: 13-23, 2000.
2. Bowlus CL, McQuillan JJ, and Dean DC. Characterization of three different elements in the 5'-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. J Biol Chem 266: 1122-1127, 1991.
3. Cagliero E, Roth T, Roy S, Maiello M, and Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem 266: 14244-14250, 1991.
4. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, and Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 16: 393-407, 2000.
5. Chen S, Apostolova MD, Cherian MG, and Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest 80: 1311-1321, 2000.
6. Chen F, Castranova V, and Shi X. New insights into the role of nuclear factor-κB in cell growth regulation. Am J Pathol 159: 387-397, 2001.
7. Chen S, Evans T, Deng D, Cukiernik M, and Chakrabarti S. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 90: 86-94, 2002.
8. Chen S, Evans T, Mukherjee K, Karmazyn M, and Chakrabarti S. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J Mol Cell Cardiol 32: 1621-1629, 2000.
9. Deng D, Evans T, Mukherjee K, Downey D, and Chakrabarti S. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42: 1228-1234, 1999.
10. Evans T, Deng DX, Chen S, and Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 49: 662-666, 2000.
11. Evans T, Xi Deng D, Mukherjee K, Downey D, and Chakrabarti S. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats. Diabetes Res Clin Pract 48: 75-85, 2000.
12. Gallois C, Habib A, Tao J, Moulin S, Maclouf J, Mallat A, and Lotersztajn S. Role of NF-kappa B in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 273:23183-23190, 1998.
13. Ghosh S and Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344: 678-682, 1990.
14. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, and Haller H. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 81: 363-371, 1997.
15. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, and Baeuerie PA. Rapid proteolysis of IB is necessary for activation of transcription factor NF-κB. Nature 365: 182-185, 1993.
16. Ishii H, Koya D, and King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76: 21-31, 1998.
17. Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli G, Guido F, and Li N. Oxidative stress and gene expression: the AP-1 and NF-kappa B connections. Biofactors 15: 87-89, 2001.
18. King GL and Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 25: 255-270, 1996.
19. Lee JI, Ganster RW, Geller DA, Burckart GJ, Thomson AW, and Lu AL. Cyclosporine inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation 68: 1255-1263, 1999.
20. Lee BH, Kim MS, Rhew JH, Park RW, de Crombrugghe B, and Kim IS. Transcriptional regulation of fibronectin gene by phorbol myristate acetate in hepatoma cells: a negative role for NF-kappa B. J Cell Biochem 76: 437-451, 2000.
21. Levin ER. Endothelins. N Engl J Med 333: 356-363, 1995.
22. Levin ER. Endothelins as cardiovascular peptides. Am J Nephrol 16: 246, 1996.
23. Lin YZ, Yao SY, Veach RA, Torgerson TR, and Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membranepermeable motif and nuclear localization sequence. J Biol Chem 270:14225-14228, 1995.
24. Madri JA, Pratt BM, and Yannariello-Brown J. Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol 132: 18-27 1988.
25. Mistry R, Golding N, and Challiss RA. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I-and II-selective metabotropic glutamate receptor agonists. Br J Pharmacol 123: 581-589, 1998.
26. Mizutani M, Kern TS, and Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97: 2883-2890, 1996.
27. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, and Nawroth PP. The role of oxidative stress and NF-kappa B activation in late diabetic complications. Biofactors 10: 157-167, 1999.
28. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, and Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 101: 1905-1915, 1998.
29. Muller DN, Mervaala EM, Schmidt F, Park JK, Dechend R, Genersch E, Breu V, Loffler BM, Ganten D, Schneider W, Haller H, and Luft FC. Effect of bosentan on NF-kappa B, inflammation, and tissue factor in angiotensin II-induced endorgan damage. Hypertension 36: 282-290, 2000.
30. Nishio Y, Kashiwagi A, Taki H, Shinozaki K, Maeno Y, H, Maegawa H, Haneda M, Hidaka H, Yasuda H, Horiike K, and Kikkawa R. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes 47: 1318-1325, 1998.
31. Pendurthi UR, Williams JT, and Rao LVM. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Arterioscler Thromb Vasc Biol 17: 3406-3413, 1997.
32. Pieper GM and Riaz-ul-Haq. Activation of nuclear factor-kappa B in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30:528-532, 1997.
33. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, and Nawroth PP. Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells. Diabetes 49: 1561-1570, 2000.
34. Roy S, Cagliero E, and Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci 37: 258-266, 1996.
35. Roy S and Lorenzi M. Early biosynthetic changes in the diabetic like retinopathy of galactose fed rats. Diabetologia 39: 735-738, 1996.
36. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, and Boyd MR. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827-4833, 1988.
37. Shaulian E and Karin M. AP-1 as regulator of cell life and death. Nat Cell Biol 4: E131-E136, 2002.
38. Shono T, Ono M, Izumi H, Jimi SI, Matsushima K, Okamoto T, Kohno K, and Kuwano M. Involvement of the transcription factor NF-kappa B in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 16:4231-4239, 1996.
39. Tamura K, Nyui N, Tamura N, Fujita T, Kihara M, Toya Y, Takasaki I, Takagi N, Ishii M, Oda K, Horiuchi M, and Umemura S. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 273:26487-26496, 1998.
40. Zhou D, Brown SA, Yu T, Chen G, Barve S, Kang BC, and Thompson JS. A high dose of ionizing radiation induces tissue-specific activation of nuclear factor kappa B in vivo. Radiat Res 151:703-709, 1999.